Adrian D. Hrabar

National University of Quilmes

Publishes on Lipoproteins and Cardiovascular Health, Atrial Fibrillation Management and Outcomes, Cardiovascular and exercise physiology. 29 papers and 6.5k citations.

29Publications

6.5kTotal Citations

Lipoproteins and Cardiovascular Health Atrial Fibrillation Management and Outcomes Cardiovascular and exercise physiology Coronary Artery Anomalies Diabetes, Cardiovascular Risks, and Lipoproteins

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al.|The Lancet|2019

Cited by 3kOpen Access

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al.|The Lancet|2017

Cited by 875Open Access

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al.|The Lancet|2017

Cited by 755Open Access

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al.|The Lancet|2019

Cited by 622Open Access

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al.|The Lancet Infectious Diseases|2021

Cited by 172Open Access